Browse studies, page 1154

Page 1154 of 1,159, newest first. Search them all at once, ranked by relevance, in Evidence Hub.

• QT prolongation in participants receiving bedaquiline-containing regimens: analysis of data from Phase 3 STREAM Stage 2 IJTLD open, 2026
• Deriving Dosages for Levofloxacin Tuberculosis Preventive Treatment for Young People Exposed to Rifampicin-Resistant Tuberculosis The Journal of infectious diseases, 2025
• Clinical response to clozapine in Black people with psychosis: A secondary analysis of an open-label clinical trial Therapeutic advances in psychopharmacology, 2026
• Factors Predictive of Early Discontinuation of Preventive Treatment in Children With Household Exposure to Multidrug-resistant Tuberculosis Open forum infectious diseases, 2025
• Analysis of the impact of national centralized volume-based procurement drug policy on the market dynamics of tuberculosis drugs BMC health services research, 2026
• A Silent Saboteur of Immunotherapy: Antibiotic Use and Its Impact on Immune Checkpoint Inhibitors Efficacy, a Systematic Review and Meta-Analysis of Recent Studies Cancers, 2026
• Limited Role of Mycoplasma genitalium, Chlamydia trachomatis, and Neisseria gonorrhoeae in Pelvic Inflammatory Disease and Tubo-Ovarian Abscess in the Netherlands: A Multicenter Prospective Cohort Study Obstetrics and gynecology international, 2026
• Case Report: Pulmonary nocardiosis: three case reports and literature review Frontiers in medicine, 2026
• Prophylactic azithromycin for chronic lung allograft dysfunction following lung transplantation: a systematic review and meta-analysis Journal of thoracic disease, 2025
• Benzoxaborole-Based Inhibitors Block LexA Autocleavage and Suppress SOS-Dependent Adaptive Phenotypes in Escherichia coli Antibiotics (Basel, Switzerland), 2026
• Economic Evaluation of Empirical and Tailored Helicobacter pylori Eradication Strategies Including Second-Line Therapy The Korean journal of helicobacter and upper gastrointestinal research, 2026
• Screening and tuberculosis preventive treatment among household contacts of drug-resistant tuberculosis patients: a scoping review BMC infectious diseases, 2026
• Epidemiological Characteristics and Antimicrobial Resistance of Prototheca Isolated in China During 2002-2024 Infection and drug resistance, 2026
• Levofloxacin-Induced Cutaneous Adverse Reactions: Characteristics and Rational Use Strategies Medical science monitor : international medical journal of experimental and clinical research, 2026
• Prevalence of primary Helicobacter pylori antibiotic resistance in Europe over the past four decades Gut microbes, 2026
• Antimicrobial resistance trends among dominant pathogens in six clinical departments of the Fourth Affiliated Hospital of Guangxi Medical University, 2020-2024 Frontiers in public health, 2026
• Bacteriological Spectrum and Antibiotic Utilization in Community-Acquired Pneumonia: An Observational Study at a Tertiary Care Center in Western Uttar Pradesh, India Cureus, 2026
• A Multifunctional Bioactive Nanoscale Coating Deposited by Atmospheric Pressure Plasma Polymerization of Peppermint Essential Oil Small (Weinheim an der Bergstrasse, Germany), 2026
• Dietary Intake Analyses for the Pharmacometrics to Advance Novel Regimens for Drug-resistant Tuberculosis (PandrTB) Pharmacokinetic Sub-Study of the endTB and endTB-Q Clinical Trials 2026
• Ceftolozane/Tazobactam for Complex and Resistant Infections: Systematic Reviews of Comparative Efficacy Studies Antibiotics (Basel, Switzerland), 2026
• QT prolongation risk factors and a monitoring strategy in rifampicin-resistant tuberculosis: Findings from the STREAM Stage 2 trial 2025
• Levofloxacin 750 mg QD for five days versus amoxicillin/clavulanate 875 mg/125 mg BID for ten days for treatment of acute bacterial exacerbation of chronic bronchitis: a post hoc analysis of data from severely ill patients Clinical therapeutics, 2006
• Analysis of patients with diabetes and complicated intra-abdominal infection or complicated urinary tract infection in phase 3 trials of ceftolozane/tazobactam BMC infectious diseases, 2017
• QT prolongation risk factors and a monitoring strategy in rifampicin-resistant tuberculosis: Findings from the STREAM Stage 2 trial PLOS global public health, 2026
• Fluoroquinolone prophylaxis in patients with neutropenia: a meta-analysis of randomized placebo-controlled trials European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2008
• Helicobacter pylori Antibiotic Resistance in Russia: A Systematic Review and Meta-Analysis Antibiotics (Basel, Switzerland), 2025
• Association of levofloxacin resistance with mortality in adult patients with invasive pneumococcal diseases: a post hoc analysis of a prospective cohort Infection, 2013
• Fluoroquinolones versus trimethoprim-sulfamethoxazole for the treatment of Stenotrophomonas maltophilia infections: a systematic review and meta-analysis Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2019
• Global Population Structure, Virulence Factors and Antibiotic Resistance of Helicobacter pylori: A Pooled Analysis of 4067 Isolates From 76 Countries Helicobacter, 2025
• Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006 Clinical therapeutics, 2007
• Quality of Life and Patient Satisfaction at 7-Year Follow-up of Antibiotic Therapy vs Appendectomy for Uncomplicated Acute Appendicitis: A Secondary Analysis of a Randomized Clinical Trial JAMA surgery, 2020
• Regional difference of antibiotic resistance of helicobacter pylori strains in Korea The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2011
• Cardiac events after macrolides or fluoroquinolones in patients hospitalized for community-acquired pneumonia: post-hoc analysis of a cluster-randomized trial BMC infectious diseases, 2019
• Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae: a pooled analysis of Phase 3 clinical trials The Journal of antimicrobial chemotherapy, 2017
• Levofloxacin for the treatment of pneumonia caused by Streptococcus pneumoniae including multidrug-resistant strains: pooled analysis Current medical research and opinion, 2009
• Effects of three fluoroquinolones on QT analysis after standard treatment courses Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2006
• Efficacy of ceftolozane/tazobactam versus levofloxacin in the treatment of complicated urinary tract infections (cUTIs) caused by levofloxacin-resistant pathogens: results from the ASPECT-cUTI trial The Journal of antimicrobial chemotherapy, 2016
• Changes of resistance rates in Pseudomonas aeruginosa strains are unrelated to antimicrobial consumption in ICU populations with invasive device-related infection Medicina intensiva, 2020
• Sonication versus the conventional method for evaluation of the dental microbiome: a prospective pilot study BMC oral health, 2022
• Moxifloxacin and glucose homeostasis: a pooled-analysis of the evidence from clinical and postmarketing studies Drug safety, 2004
• Comparative Efficacy and Safety of Moxifloxacin and Levofloxacin in a Short Standardised Rifampicin Resistant TB Regimen: A STREAM 2 Secondary Analysis Tropical medicine and infectious disease, 2024
• Comparison of the effects of levofloxacin on QT/QTc interval assessed in both healthy Japanese and Caucasian subjects (pages British journal of clinical pharmacology, 2012
• High Levels of Treatment Success and Zero Relapse in Multidrug-Resistant Tuberculosis Patients Receiving a Levofloxacin-Based Shorter Treatment Regimen in Vietnam Tropical medicine and infectious disease, 2020
• Levofloxacin for treatment of ventilator-associated pneumonia: a subgroup analysis from a randomized trial Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005
• Treatment Outcomes of Isoniazid-Resistant (Rifampicin Susceptible) Tuberculosis Patients in Uzbekistan, 2017-2018 International journal of environmental research and public health, 2021
• Levofloxacin treatment of active tuberculosis and the risk of adverse events Chest, 2005
• Assessment of nationally recommended antibiotics for treatment of UTI in U.S.-Mexico border emergency departments The American journal of emergency medicine, 2022
• The Efficacy and Safety of Minocycline-Containing Quadruple Therapies Against Helicobacter pylori Infection: A Retrospective Cohort Study Infection and drug resistance, 2024
• A Randomized, Observer-Blinded, Active-Controlled, Phase IIIb Study to Compare IV/Oral Delafloxacin Fixed-Dose Monotherapy With Best Available Treatments in a Microbiologically Enriched Population With Surgical Site Infections: The DRESS Study Open forum infectious diseases, 2025
• Clinical utility of oral Nemonoxacin 500 mg once daily for the treatment of acute lower urinary tract infections: a prospective open-label, multicenter study BMC infectious diseases, 2025
• Efficacy of adding levofloxacin to gemcitabine and nanoparticle-albumin-binding paclitaxel combination therapy in patients with advanced pancreatic cancer: study protocol for a multicenter, randomized phase 2 trial (T-CORE2201) BMC cancer, 2024
• Rifasutenizol-based triple therapy versus bismuth plus clarithromycin-based triple therapy for first-line treatment of Helicobacter pylori infection in China (EVEREST-HP): a phase 3, multicentre, randomised, triple-dummy, double-blind, controlled, non-inferiority trial The Lancet. Infectious diseases, 2026
• Efficacy and in vitro activity of gepotidacin against bacterial uropathogens, including drug-resistant phenotypes, in females with uncomplicated urinary tract infections: results from two global, pivotal, phase 3 trials (EAGLE-2 and EAGLE-3) Antimicrobial agents and chemotherapy, 2025
• Base curves of bandage contact lenses and their effects on post Trans-PRK vision and pain: the study protocol for a randomized clinical trial Trials, 2025
• Pharmacokinetics and Safety of Clofazimine in Children With Rifampicin-Resistant Tuberculosis The Journal of infectious diseases, 2025
• Belantamab mafodotin, lenalidomide, and dexamethasone for intermediate-fit and frail patients with newly diagnosed myeloma Blood, 2026
• Infections in patients receiving daratumumab for newly diagnosed multiple myeloma: a pooled analysis of MAIA and ALCYONE Blood advances, 2026
• Ciprofloxacin versus levofloxacin prophylaxis in hematopoietic stem cell transplantation: A randomized trial International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2024
• Study protocol for a multicenter, multinational prospective randomized controlled trial comparing outcomes in subjects with Gram-negative bacteremia who have blood culture evaluation using Fast Antibiotic Susceptibility Testing vs. standard of care testing: the FAST trial Trials, 2025
• Comparison of remimazolam versus propofol under deep sedation for elderly patients during prostate biopsy: a protocol for a randomised controlled trial BMJ open, 2026
• Prime Editing for p47phox-Deficient Chronic Granulomatous Disease The New England journal of medicine, 2026
• Venetoclax in combination with cytarabine with or without idarubicin or azacitidine in children, adolescents, and young adults with relapsed or refractory acute myeloid leukaemia (VENAML): a multicentre, phase 1 expansion study The Lancet. Haematology, 2026
• Impact of drug-resistance diagnosis based on whole-genome sequencing on the treatment adequacy of patients with drug-resistant pulmonary tuberculosis in the state of São Paulo, Brazil: a protocol for a non-randomised controlled trial (Gen-TB PróCura) BMJ open, 2025
• Application of directional customized corneal relaxing incision in EVO ICL implantation: high myopia with low astigmatism BMC ophthalmology, 2026
• Efficacy of 1.5% levofloxacin otic solution in treating acute otitis externa: A post hoc analysis of ENT103-3001, a multicenter randomized double-blind parallel-group placebo-controlled phase III study in otitis media with persistent otorrhea Auris, nasus, larynx, 2024
• Efficacy of susceptibility-guided quadruple therapy with antibiotic resistance using the string test coupled with quantitative PCR for Helicobacter pylori eradication: a protocol of a multicentre, open, randomised clinical trial BMJ open, 2024
• Tildrakizumab for the prophylaxis of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation Blood advances, 2026
• Study protocol for a duration-randomized clinical trial to determine the optimal length of treatment for multidrug-resistant tuberculosis with a 5-drug regimen: The DRAMATIC trial Contemporary clinical trials, 2025
• Effectiveness and safety of shortened intensive treatment for children with tuberculous meningitis (SURE): a protocol for a phase 3 randomised controlled trial evaluating 6 months of antituberculosis therapy and 8 weeks of aspirin in Asian and African children with tuberculous meningitis BMJ open, 2025
• Pharmacokinetics, bactericidal activity and toxicity of short oral regimens for rifampicin-resistant tuberculosis treatment Nature communications, 2026
• Safety of liposomal daunorubicin-cytarabine (CPX-351) in secondary AML: Japanese phase 1/2 study and global phase 3 study International journal of hematology, 2025
• A non-randomized pragmatic historically controlled trial evaluating the effectiveness and safety of a bedaquiline or a linezolid-based short regimen for rifampicin-resistant tuberculosis The Journal of infection, 2024
• A Prospective Cohort Study on the Usage, Safety, and Efficacy of Delamanid in Patients With Pulmonary Multidrug-Resistant Tuberculosis in South Korea Open forum infectious diseases, 2025
• Evaluation of an oral bedaquiline regimen for treating multidrug-resistant TB in China: a randomized trial Infection, 2026
• Vonoprazan-Amoxicillin Dual Therapy with or Without Saccharomyces boulardii Supplementation as a Rescue Regimen for Helicobacter pylori Infection Infection and drug resistance, 2026
• Lascufloxacin switch therapy versus ampicillin/sulbactam for older patients with community-acquired pneumonia in Japan (STEP study): a study protocol for a multicentre open-label randomised controlled non-inferiority trial BMJ open, 2026
• Effectiveness of Doxycycline in Combination With Other Antibiotics for Gram-Positive Periprosthetic Joint Infections: A Causal Inference Study Open forum infectious diseases, 2026
• Intensified Treatment of Tuberculous Meningitis in Adults: A Systematic Review and Meta-analysis Open forum infectious diseases, 2025
• Protecting households on exposure to newly diagnosed index multidrug-resistant tuberculosis patients: Study protocol for the PHOENIx phase 3 clinical trial Contemporary clinical trials, 2025
• The Use of Step-Down Oral Antibiotic Therapy for Uncomplicated Gram-Negative Bacteremia and Risk Factors for Adverse Outcomes Open forum infectious diseases, 2026
• Hypoalbuminemia and reduced sputum microbiome diversity associated with antibiotic treatment failure in nursing and healthcare-associated pneumonia Drug discoveries & therapeutics, 2026
• Direct stimulation of acupuncture at extraocular muscle attachment point for 13 cases of acquired extraocular muscle palsy Zhongguo zhen jiu = Chinese acupuncture & moxibustion, 2025
• Bismuth-Based quintuple therapy: a step beyond quadruple regimens in H. Pylori treatment and the impact of patient compliance BMC gastroenterology, 2025
• Population-based study of pharmacogenetics and pharmacokinetics in Southern African patients with multidrug-resistant tuberculosis (PoPG): a protocol for the Namibian cohort BMJ open, 2026
• Administration of levofloxacin combined with metronidazole suppositories prior to in vitro fertilisation in women with chronic endometritis: a protocol of a single-centre, randomised, controlled clinical trial BMJ open, 2025
• Cefadroxil as Oral Transitional Therapy for Gram-Positive Bacteremia With or Without Non-Vertebral Osteomyelitis: A Multicenter Retrospective Cohort Study Open forum infectious diseases, 2026
• Pharmacokinetics and safety of MP-376 (levofloxacin inhalation solution) in cystic fibrosis subjects Antimicrobial agents and chemotherapy, 2011
• Levofloxacin prophylaxis to prevent bacterial infection in chemotherapy-induced neutropenia in acute leukemia Bangladesh Medical Research Council bulletin, 2009
• The effects of levofloxacin on ECG parameters and late potentials American journal of therapeutics, 2005
• Assessment of musculoskeletal toxicity 5 years after therapy with levofloxacin Pediatrics, 2014
• Phase II clinical trial for prevention of delayed diarrhea with cholestyramine/levofloxacin in the second-line treatment with irinotecan biweekly in patients with metastatic colorectal carcinoma Oncology, 2007
• Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication Alimentary pharmacology & therapeutics, 2010
• Levofloxacin treatment in patients with rheumatoid arthritis receiving methotrexate Southern medical journal, 2007
• Comparing the Efficacy of Sequential and Standard Quadruple Therapy for Eradication of H. Pylori Infection Acta medica (Hradec Kralove), 2020
• The clinical and bacteriological factors for optimal levofloxacin-containing triple therapy in second-line Helicobacter pylori eradication PloS one, 2014
• Pharmacokinetics of multiple intravenous instillation of levofloxacin in Chinese healthy subjects Acta pharmacologica Sinica, 2002
• Intrapulmonary concentration of levofloxacin in patients with idiopathic pulmonary fibrosis Pulmonary pharmacology & therapeutics, 2014
• Aqueous and vitreous penetration of linezolid and levofloxacin after oral administration Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2010
• Levofloxacin in the treatment of acute and bacteriologically documented sinusitis with high risk of complications Medecine et maladies infectieuses, 2005
• Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial Gut, 2010